Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EverCell Bio is a specialized biotechnology company providing highly customized human induced pluripotent stem cell (iPSC) services—including reprogramming, gene editing, differentiation into various lineages (neural, hepatic, cardiac), data generation and validation—to academic institutions as well as biotech and pharma clients. Their advisory team has over 30 years of combined experience in the field. They focus on delivering high-quality custom solutions to accelerate regenerative medicine discovery and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EverCell Bio.